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Abstract
Nonagenarians are the fastest growing sector of populations across Western European and the developed world. They 
are some of the oldest members of our societies and survivors of their generation and may help us understand how to 
age not only longer, but better.
The Belfast Longevity Group enlisted the help of 500 community-living, mobile, mentally competent, 'elite' 
nonagenarians, as part of an ongoing study of ageing. We assessed some immunological, cardiovascular, nutritional 
and genetic factors and some aspects of their interaction in this group of 'oldest old'.
Here we present some of the evidence related to genetic and nutritional factors which seem to be important for good 
quality ageing in nonagenarians from the Belfast Elderly Longitudinal Free-living Ageing STudy (BELFAST).
Background
Nonagenarians are the oldest members of our societies
and survivors of their generation. But what are the factors
which help people reach their ninetieth birthday in good
condition? Are they genetics as in 'nature' or do they
depend on 'nurture' and are related to environment, or
are both factors inextricably intertwined?
The Belfast Longevity Group has argued that in order
to age successfully, it seems necessary to have a combina-
tion of facilitatory genes and appropriate nutrition to
drive
a) a competent immune system, and provide b) a
favourable cardiovascular risk profile
Here we present some of the evidence related to genetic
and nutritional factors which seem to be important for
good quality ageing in nonagenarians from the Belfast
Elderly  Longitudinal  Free-living  Ageing  STudy (BEL-
FAST).
BELFAST Study
Subjects and Methods
In the BELFAST study, 90 year old subjects, who are 'very
good' for their age, also called 'elite' (approximately 500),
were recruited through their General Practitioners, from
the Greater Belfast area [1,2]. Subjects willing to enrol,
were community-living, mobile, and mentally competent
(> 26/30), [3] and gave written Ethical Consent, Queens
U nive rs it y Be lfas t.  Bri efl y ,  su bjects ga ve bl ood sa m pl es
for DNA and other laboratory variables, responded to
nutrition, life style and medical history questionnaires
and had Blood Pressure and anthropometric measure-
ments taken [2,4].
Immunology of BELFAST Nonagenarians
An effective immune system needs 3 major components
which are influenced by both nutrition and by genes
• Innate Immune Response - neutrophils and natural 
killer cells (NK)
• Cell-mediated Immunity - through lymphocyte sub-
sets research
• Cytokines - the immune hormonal messengers
Innate Immune System
Neutrophil Function
In early work on neutrophils, we showed that chemotaxis
appeared unchanged in 'elite' nonagenarian subjects
compared to younger people. In terms of neutrophil
engulfment, phagocytosis was modestly reduced in older
males compared to female nonagenarians and younger
subjects, Table 1. Killing of Staphylocccus aureus was
equal across both age groups though myeloperoxidase
activity, a measure of oxidative killing capacity, appeared
none significantly lower in older women [5]. However in
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general, there is a dearth of information about neutrophil
function with respect to ageing, and what information is
available has been somewhat contradictory and difficult
to interpret [6-8]. Some groups have reported similar
findings to those of the BELFAST study in that centenari-
ans seem to have better neutrophil function compared to
those in the 'younger' old groups [9], and normal chemot-
axis has been associated with better survival [10]. How-
ever neutrophil immunology has been relatively under
researched and much further work requires to be carried
out in this area.
Natural Killer Cells (NK) and NKT-related cells
Natural killer cells provide the highly important innate
immune response which is first-line and widely con-
served thorough out nature. Their role is to target and kill
virally infected, tumorigenic or other abnormal cells.
They kill by releasing cytotoxic molecules, stored in cyto-
plasmic secretory lysosomes. NK cell numbers have been
noted to be increased in many studies related to ageing
[11-15], where it is thought that they scan the immuno-
logical landscape and deal with the increased susceptibil-
ity to tumourigenesis, which comes with increasing age.
Like other studies in the oldest old, BELFAST nonagenar-
ians showed increased numbers of NK cells [16].
However, the BELFAST Longevity Group, was the first
to identify increases in other NKT-related cells [16]
which are now considered to act as first responders and
serve as a bridge between the innate and adaptive
immune system. NKT cells recognize lipid antigens
rather than peptides, and respond to these when pre-
sented by a non-classical class I MHC molecule, CD1d.
NKT cells constitute a minor lymphocyte population
that exhibits features of both T cells and NK cells. They
seem to play a pathogenic role in disease, have immune-
regulatory properties, in part based on their cytokine
profile, though in cancer, there is evidence that they can
both activate or suppress anti-tumour immunity [17].
Recent research on the CD56 (bright) NK cell subset con-
firms that these cells are numerically in the minority in
peripheral blood but constitute the majority of NK cells
in secondary lymphoid tissues. Although increased in
ageing, the actual role of NKT cells is not yet completely
understood, though like NK cells, they seems to be
important in first-line immune surveillance though per-
haps against a different spectrum of abnormal cells.
NK cells and Nutrition
NK cells and their cytolytic activity have been related to
nutrition including Vitamin D and anthropometric mark-
ers [18]. In preliminary work, there appears to be a small
negative relationship between NK cell number and BMI
in the BELFAST study (r2 = 0.36; p = 0.03), though to date
this has not been fully explored (Figure 1).
Genetics and NK cells
The functions of human natural killer (NK) cells are con-
trolled by diverse families of antigen receptors. Promi-
nent among these are the killer cell immunoglobulin-like
receptors (KIR), a family of genes clustered in one of the
most variable regions of the human genome. The KIR
genes can be classified into A or B haplotypes, with A
having a more inhibitory role, compared to the more acti-
vating role of B, on NK cell function. Considering that
KIR genes might have an influence in longevity, we
assessed KIR gene frequency in BELFAST nonagenarians
but noted no differences in the major or grouped allele
frequencies [19], though the study may have been under-
powered, for the large number of KIR haplotypes identi-
fied.
In addition to genetic diversification, the KIR gene
complex also shows differences at the functional level
with different alleles having different protein expression
levels and different avidity with their HLA ligand. We
grouped BELFAST nonagenarians by A and B KIR haplo-
types and showed in a preliminary study that there was a
predominance of the pro-inflammatory cytokines with
the B group of KIR genes [20]. We consider that this may
be important in explaining, the pro-inflammatory back-
ground found with increasing age or inflamm-ageing
[21], and could provide an explanation for, or be a conse-
Table 1: Neutrophil Phagocytosis of Staphylococcus aureus
Elderly Male 61%
Young Male 64%
Elderly Female 70%
Young Female 66%
P = 0.05
Adapted from Rea IM, 1988
Figure 1 NK cells and BMI in BELFAST study.Rea Immunity & Ageing 2010, 7:6
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quence of, the increased number of NK and NKT-related
cells, found in the very old [16,17].
Cell-Mediated Immunity
Lymphocyte subsets
BELFAST nonagenarians [22,23] showed a range of
changes in lymphocyte subsets which seem to be related
to their advanced age and generally replicate other stud-
ies [14,15]. CD3 lymphocytes were apparently unchanged
in number, though CD4 naïve cells decreased in our
cross-sectional study, in both male and female nonage-
narians, compared to younger cohorts [22]. We found
that CD8 cell numbers remained unchanged for BEL-
FAST 'elite' nonagenarians unlike other studies where
CD8 cells appeared to accumulate with age, though sub-
ject groups may not be 'elite', as with us. Recent studies
suggest that CD8 T cells may be age-sensitive by at least
two partially independent mechanisms: fragile homeo-
static control and gene expression instability in a large set
of regulatory cell surface molecules [24].
CD4 lymphopenia and nutrition
Lymphopenia, < 1.5 × 109, is considered a marker for pro-
tein energy malnutrition in children and adults [25]. In
BELFAST nonagenarians, in keeping with others [26-28],
we noted a fall in CD4 count with increasing age [22] and
this has been reported as a fairly universal association
with very advanced age. A decline in CD4 count, a rise in
CD8 compartment and an increase in the NK cell num-
bers has been considered as a 'remodelling' of the
immune compartment with ageing.
In BELFAST subjects, we had previously shown an
association between the CD4 count and some nutritional
markers [29], suggesting that potentially reversible nutri-
tional and/or inflammation-related factors could be
responsible for the CD4 lymphopenia in our aged group.
From France and Japan other researchers also reported
similar unexplained CD4 lymphopenia in 80 year olds
[30,31].
In the BELFAST group the CD4 count was weakly and
negatively correlated to albumin levels, though many
older subjects in the BELFAST study also showed CD4
lymphopenia, where albumin values were well within the
normal range Figure 2. These findings raised the possibil-
ity in our thinking, that nutrition and/or inflammation
might play a part in CD4 lymphopenia associated with
ageing.
CD4/CD8 Ratio and Ageing
In 2008, Wikby's group in their NONa study [32] sug-
gested that low CD4/CD8 ratio was a biomarker for
reduced survival. Factors associated with Immune Risk
Profile (IRP) were an associated cytomegalic virus index
and a clonal predominance in subsets. In contrast to
Wikby's finding, a preliminary analysis in BELFAST
nonagenarians showed that the CD4/CD8 ratio was well
maintained Figure 3 with increasing age [33]. However, to
date, cytomegalic virus markers have not been measured
in the BELFAST study and this would be important infor-
mation to help interpret the different findings. Lately, the
Wikby group have also reported findings of no change in
CD4/CD8 ratio for centenarian survivors [34] arguing
that centenarians are a special group, similar to findings
in 'elite' BELFAST study subjects. The jury therefore
remains 'out' as to whether a low or declining CD4/CD8
ratio in elderly people is a poor prognostic sign, or
whether it is potentially reversible, if nutrition and/or
infection resolve.
Cytokines -Serum and Supernatant
Ageing is associated with an increased pro-inflammatory
profile which was described by Franceschi as INFLAMM-
AGEING [21]. The BELFAST study generally showed
similar changes with an increase in pro-inflammatory
Figure 2 CD4 count and Albumin in BELFAST study.
Figure 3 CD4/CD8 ratio in BELFAST study.
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serum cytokines i.e. IL-6, IL-12 and TNFα. In addition
BELFAST subjects showed an accompanying increase in
soluble IL-6 receptor and the IL-12p40 fraction. This sug-
gested that the soluble cytokine factors both reduce and
buffer the biological effect of their respective cytokines
[35-37]. These effects were equally present in male and
female elderly subjects. In general, the anti-inflammatory
cytokines showed less change with increased age, in that
IL-10 showed a modest increase, whereas the anti-
inflammatory and 'active' form of TGFβ showed no
apparent age-related change [35].
We wondered where the site of production of the
increased cytokine profile might be located, since the
finding had been replicated across several groups. In later
work we showed that IL-6, IL-2 and IL-12 were produced
spontaneously, not only by separated monocytes [35-37],
b u t  a l s o  f r o m  l y m p h o cy t e s.  W e  s u b s e q u e n t l y  s e t  u p  a
methodology for intracellular identification of cytokines
and demonstrated that IL-2, IL-6 and TNFα were pro-
duced from intracellular domains in stimulated lympho-
cytes [38].
Genes and Cytokines
Cytokine genes control cytokines and act like immune
hormones to orchestrate the serum and tissue levels of
the cytokines which drive the immune response.
Cytokine polymorphisms have functional effects and
determine serum cytokine responsiveness to stressors,
including exercise and infections [39,35]. In early work on
cytokine genes and the effect of genes on cytokines, we
were the first to show that the IL-6 gene not only affects
IL-6 production through its C and G alleles, but also
affects the anti-inflammatory partner IL-10 and soluble
IL-6 receptor in a reciprocal fashion [37]. This suggests
that cytokine alleles which are high cytokine producers
may also produce higher levels of their reciprocal soluble
receptors and their partner anti-inflammatory cytokines
and that the acute 'stress' responses are highly buffered
and controlled in life, when people are well. It is possible
that as people become older, the homeostatic 'immune
thermostat' and buffering mechanism becomes blunted,
responses become less focused with the timing out of
sequence, and this leads to low grade chronic inflamma-
tion, and age-related disease.
In 2003 we were one of the first groups to conduct a
large scale study into cytokine gene polymorphisms
[39,40]. We argued that cytokine genes, in controlling and
modulating immune responsiveness, might be important
in longevity and show a change in polymorphism allele
frequency in old age. Together with others we hypothe-
sised that cytokine gene alleles, associated with a strongly
pro-inflammatory response, could contribute to survival
from childhood infections, but might drive immune acti-
vation and increase age-related disease [40]. Conversely
cytokine polymorphisms which increased the anti-
inflammatory profile, might well contribute to a more
modulated response to mid life 'stressors' and age-related
disease and contribute to better quality ageing [41].
The BELFAST nonagenarian group, showed some attri-
tion of the IL-6 GG allele in very aged persons, but other-
wise gene allele frequencies for most of the cytokine
polymorphisms were largely unchanged with longevity
[39]. A major criticism could be that the study was insuf-
ficiently powered and in an attempt to address this on a
larger scale, a meta-analysis of the effect of IL-6 and lon-
gevity was carried out, across some centres in Europe.
This study suggested that IL-6 has different allele fre-
quencies across Europe, with a north to south axis. There
may also be differential effects of the G/C alleles across
countries, since only the 3 Italian centres showed an asso-
ciation between the G allele and longevity [42].
More and larger cytokine gene studies need to be car-
ried out since there is evidence that cytokine alleles pro-
duce different functional effects dependent upon tissue
and cellular milieu [43,44]. The IL-6 gene may also have
an environmental trigger or inhibitor which can modify
or modulate its role. It has been postulated that IL-6 pro-
duction and gene switching might be modulated by the
Mediterranean diet as has been noted in cellular studies
[45,46] with similar changes suggested as contributing to
differences between Northern and Southern European
incidence, and mortality from vascular disease. However
early human studies have not provided much support for
this hypothesis [47], though there is evidence that a 'Med-
iterrean' type diet may reduce the incidence of mortality
from cardiovascular disease [48]. Larger studies and
meta-analyses are therefore needed to circumvent the
power issues, and should be addressed in larger genetic
and life-style research such as the EU Genetics of Healthy
Ageing study [49].
Cardiovascular Risk and BELFAST Nonagenarians
Several major factors associated with cardiovascular risk
have been measured in the BELFAST study and some are
discussed in relation to nutrition and genetic profile.
• Blood Pressure and anthropometric and dietary 
variables
• Cholesterol, High Density Lipoprotein (HDL), Low 
Density Lipoprotein (LDL)
• Genotypes previously related to increased cardio-
vascular risk
Blood Pressure
Blood Pressure and Anthropometric Variables Blood
pressure is the most important risk factor for heart dis-
ease and stroke [50]. In BELFAST nonagenarians, mean
blood pressure was 137 and 84 mmHg for systolic and
diastolic blood pressure respectively, with no difference
between males and females (p = 0.57; p = 0.48 respec-
tively). The mean BMI for both male and female nonage-Rea Immunity & Ageing 2010, 7:6
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narians was approximately 24.5 with no sex-related
difference (p = 0.79).
In the BELFAST study, we found that tertiles of blood
pressure were variously associated with BMI, weight and
skin fold thickness in the nonagenarian cohort, so that
higher weight, waist measurements and skinfold thick-
n e s s  i n c r e a s e d  t h e  c h a n c e  o f  h a v i n g  a  b l o o d  p r e s s u r e
above 140/90 mmHg by about 30% [2]. This surprising
finding is similar to findings in younger people, where
obesity tracks with hypertension and often with the met-
abolic syndrome [51,52], and suggests that comparable
pathogenic mechanisms may link blood pressure to
weight-related variables even in 90 year olds.
Although obesity is considered a major risk factor for
heart disease there seems to be paradox in that it also
seems protective in a range of cardiovascular-related dis-
eases [53]. A number of papers have noted that obese
people with hypertension have lower mortality or stroke
despite less effective blood pressure control. The mecha-
nism for this finding is not known. In our hands, BEL-
FAST nonagenarians seem to show a positive relationship
between measures of weight and blood pressure, but with
normal glucose [2], although the longer term outcome for
these nonagenarians is not yet known.
Obesity may be different diseases in different people
and the lean male with a family history of heart disease
may have a higher cardiovascular risk, compared to the
weightier female who has reached 89 years. Because of
our findings, we do not suggest that 90 year olds should
lose weight, but rather we raise the question as to
whether weight and blood pressure have different trajec-
tories in the 'oldest old', and whether genes related to
obesity and/or blood pressure might be differentially
expressed in the 'oldest old' in a sort of pleiotropic antag-
onism [54].
Blood Pressure and Sodium The 24 hour dietary
intakes were analysed by CompEat [CompEat nutritional
analysis program, Lifeline Nutritional Services, London].
This showed a relatively low sodium intake at approxi-
mately 2 grams daily (1836 mg for females and 2087 mg
for males), compared to population averages of 4-7 grams
daily, and this finding may contribute to the relatively
normal blood pressure found in the BELFAST nonage-
narian group [2]. Increasing tertiles of serum sodium,
a l t h o u g h  o n l y  w e a k l y  a s s o c i a t e d  t o  s o d i u m  i n t a k e  b y
dietary recall [r2 = 0.27; p = 0.046], were significantly cor-
related with increasing tertiles of blood pressure in BEL-
FAST nonagenarians (Figure 4).
This is of special interest because Feng & McGregor
have demonstrated that lower salt intake is helpful in low-
ering blood pressure measurements population-wide
[55]. Previous studies also suggest that blood pressure
can be optimised in people over 65 years with reduced
salt intake, since there is considered to be increased sen-
sitivity to salt restriction [56]. It is not known whether
this is a direct effect of sodium intake on vascular resis-
tance or a more complex gene/environment-related effect
[57], which like weight, may be differently expressed in
the 'oldest old'
Cholesterol, HDL and LDL fractions
A couple of interesting points emerged from 24 hour
dietary intake by CompEat [CompEat nutritional analysis
program, Lifeline Nutritional Services, London]. Overall
the total calorie intake was relatively low at approximately
1426 Kcals, with males taking about 200Kcals more than
female nonagenarians. According to CompEat, the aver-
age fat total for nonagenarians was approximately 57 g
distributed as 37 g of saturated fat content, 4 g polyunsat-
urates, and 16 g monosaturates. Although the total
dietary fat total could be considered low normal, the dis-
tribution shows a higher saturated fat percentage, than
might be considered optimal.
Individual serum cholesterol levels and HDL and LDL
fractions are both genetically and nutritionally deter-
mined. BELFAST nonagenarians showed a mean choles-
terol value around 5.3 umol/l for both male and female
nonagenarians, which would be considered low normal
for the local Northern Ireland population, in the absence
of treatment. HDL however, was quite well preserved in
both male and female nonagenarians with median values
of 1.3 umol/l. for female and over 1.umol/l for male nona-
genarians, though some males had values < 1.0 umole/l
which would be considered less than optimal. The HDL/
Figure 4 Tertiles of Systolic and Diastolic Blood Pressure in rela-
tion to Serum Sodium in BELFAST study. Systolic Blood Pressure. 
Tertile 1 < 120 mmHg. Tertile 2 120-140 mmHg. Tertile 3 > 140 mmHg.Rea Immunity & Ageing 2010, 7:6
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cholesterol ratio at around 3.5 is reasonably satisfactory
i n  a  g r o u p  w i t h  n o  m a j o r  r i s k  f a c t o r s ,  o t h e r  t h a n
advanced age [58].
However cholesterol and its fractions are dictated by
several genes, the most well recognised of which, is ApoE,
with the ApoE 4 allele being associated with higher cho-
lesterol and atherosclerotic clinical risk [59-61]. BEL-
FAST nonagenarians who carried the ApoE4 allele
showed higher serum cholesterol values compared to
those who carried the ApoE2 allele. The frequency of
ApoE4 allele carriage was reduced by 50% in nonagenari-
ans, compared to the local < 65 year old population [62],
suggesting that vascular-related risk and early mortality
may have had an attrition effect on the ApoE4 gene pool
in 90 year old survivors.
Genes-Apolipoprotein E gene (ApoE), Angiotensinogen 
Converting Enzyme gene (ACE) and 
MethylenetetrahydrofolateReductase Gene (MTHFR)
These three genes have alleles ie ApoE4 for ApoE, DD for
ACE and tt for MTHFR, which have been associated with
premature vascular-related disease, [63-65], including
dementia [66,67]. It has been argued that carriers of these
genes have increased risk of early vascular-related death,
whether from heart disease or dementia, and this would
be represented in nonagenarian survivors with attrition
of the 'risk' allele frequency, compared to younger age
groups.
In keeping with this hypothesis, BELFAST nonagenari-
ans, showed a fall in ApoE4 allele frequency reduced from
16% in < 65 year olds from the same geographical area,
enlisted for the MONItoring of CArdiovascular (MON-
ICA) project, down to 8% in BELF AST nonagenarians.
There was a reciprocal change in ApoE2 rising to 12% in
nonagenarians compared to 8% in < 65 year old MON-
ICA local subjects [62]. A similar decrease in ApoE4
allele frequency has been consistently noted in nonage-
narian and centenarian survivors across many European
and world-wide populations, suggesting that the BEL-
FAST study is 'fit for purpose' and has replicated other
findings [68-70].
The DD allele previously associated with early myocar-
dial infarction and death [64] was not significantly
changed in frequency in BELFAST nonagenarians and
therefore does not add support to the suggestion that
homozygous DD carriage tracks with early mortality, at
least for BELFAST nonagenarians [71]. Although the D
allele of ACE might be expected to increase blood pres-
sure, this was not the case for BELFAST octo/nonagenar-
ians and in other studies
BELFAST octo/nonagenarians also showed a non-sig-
nificant reduction in frequency of the tt allele of MTHFR
[72], which is associated with higher homocysteine, and
considered a vascular risk factor, with increased mortality
[65,73]. However the interesting and important effect
that dietary folate has in lowering homocysteine in t allele
carriers, was demonstrated to be present in octo/nonage-
narians in the BELFAST study [1]. Here a powerful gene-
nutrition effect is exemplified where dietary folate con-
sumption from green vegetables at a personal level, or in
fortification of flour at a population level, can reduce
homocysteine in t allele carriers, with the potential to
reduce vascular risk [74].
In a multiple regression analysis to assess the relative
importance of these 3 genes with respect to longevity in
BELFAST octo/nonagenarians, ApoE was the most sig-
nificant gene, with the ApoE 2 allele contributing posi-
tively, though in a modest way, to nonagenarian longevity.
The ApoE 4 allele conversely, demonstrated a negative
effect with respect to survival beyond 90 years [74]. Pre-
viously, Heijmans [75] had suggested that ApoE did not
contribute to cardiovascular mortality in old age in the
Leiden study, but did contribute significantly to Alzheim-
e r s  d e m e n t i a.  L oc a l l y  w e  w e r e  u n a b l e  t o  r e p l i ca t e  t h i s
finding, and found no difference in nonagenarian mortal-
ity outcomes to time of death for ApoE 2 compared to
ApoE4 BELFAST nonagenarians or in relation to cause of
death, as documented by death certificate [74].
Summary
Nonagenarians and centenarians are of intense interest to
scientists, since they may help us understand how to age
not only longer, but better. Ageing better is important to
each of us personally but is of enormous interest to our
governments, who recognise that healthy ageing has a
huge economic dividend for society.
BELFAST 'elite' nonagenarians show evidence of a
competent immune system, programmed with increased
NK cells to scan presumably for 'damaged' cells and all
sorts of intruders. There seems to be increasing evidence
that diet and environment can influence the immune sys-
tem and the cytokine milieu, and can modulate the body's
defence to every type of stressors-from infections to can-
cer.
Cardiovascular risk is also influenced by what we eat, or
even by what our grandmother and mother ate [76,77].
The old saying that 'what you eat is what you are' seems
increasingly to be true, as we begin to dissect out how our
genes can be modified before birth, and by our mother's
nutritional opportunities. Evidence from the Dutch fam-
ine cohort provides a clear association between the later
cardiovascular health of offspring and the mother's nutri-
tional status during pregnancy [77].
In ageing and age-related disease, there is increasing
evidence that our genes which we inherit are our 'genetic
capital', and we increasingly understand that gene expres-
sion and their effects are influenced by our environmen-
tal choices, whether they be nutritional, exercise or
stress-related, or probably also our sex-hormones. DietRea Immunity & Ageing 2010, 7:6
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and lifestyle choices are therefore key to helping our
genes facilitate better longer ageing, if we are lucky
enough to start off with good genetic 'capital'. Besides our
genes, good nutritional support and life style choices may
be able to maximise our positive genetic attributes and
minimise any damaging effects.
Like any wise strategist or fiscal planner, we each need
to take control of our destiny and plan to age better.
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